{"url_path":"/sec/rytm/8-k/2026-06-25/item-1","section_key":"item-1","section_title":"Item 1 Election of two Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1649904/0001628280-26-045569-index.html","accession_number":"0001628280-26-045569","cik":"0001649904","ticker":"RYTM","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1649904/0001628280-26-045569-index.html","primary_entity_key":"0001649904","primary_entity_name":"RHYTHM PHARMACEUTICALS, INC."},"word_count":41,"has_tables":true,"body_markdown":"Item 1 - Election of two Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.\n\nNOMINEEVotes FORVotes WITHHELDBroker Non-Votes\n\nDavid W. J. McGirr53,167,9718,704,5272,273,648\n\nDavid P. Meeker, MD59,961,8481,910,6502,273,648"}